188 related articles for article (PubMed ID: 33466237)
21. Understanding and Preventing (
White CM
Ann Pharmacother; 2020 Jun; 54(6):611-614. PubMed ID: 31771343
[No Abstract] [Full Text] [Related]
22.
Mansouri I; Botton J; Semenzato L; Haddy N; Zureik M
J Am Heart Assoc; 2022 Dec; 11(24):e8067. PubMed ID: 36533625
[TBL] [Abstract][Full Text] [Related]
23. Role of ranitidine in N-nitrosodimethylamine formation during chloramination of competing micropollutants.
Seid MG; Chung J; Choe J; Cho K; Hong SW
Sci Total Environ; 2021 Feb; 756():144156. PubMed ID: 33302063
[TBL] [Abstract][Full Text] [Related]
24. Transformation of ranitidine during water chlorination and ozonation: Moiety-specific reaction kinetics and elimination efficiency of NDMA formation potential.
Jeon D; Kim J; Shin J; Hidayat ZR; Na S; Lee Y
J Hazard Mater; 2016 Nov; 318():802-809. PubMed ID: 27381234
[TBL] [Abstract][Full Text] [Related]
25. N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer—A Longitudinal Cohort Study Based on German Health Insurance Data.
Gomm W; Röthlein C; Schüssel K; Brückner G; Schröder H; Heß S; Frötschl R; Broich K; Haenisch B
Dtsch Arztebl Int; 2021 May; 118(21):357-362. PubMed ID: 34247699
[TBL] [Abstract][Full Text] [Related]
26. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients.
Hahm KB; Kim WH; Lee SI; Kang JK; Park IS
Scand J Gastroenterol; 1995 Mar; 30(3):265-71. PubMed ID: 7770717
[TBL] [Abstract][Full Text] [Related]
27. Effects of ranitidine and nizatidine on the risk of gastrointestinal cancer.
Kang H; Nam CM; Choi DW; Park S
Front Oncol; 2023; 13():1182174. PubMed ID: 37576886
[TBL] [Abstract][Full Text] [Related]
28. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
Netzer P; Eschenmoser K; Halter F; Inauen W
Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
[TBL] [Abstract][Full Text] [Related]
29. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
30. Nitrite ion mitigates the formation of N-nitrosodimethylamine (NDMA) during chloramination of ranitidine.
Seid MG; Cho K; Lee C; Park HM; Hong SW
Sci Total Environ; 2018 Aug; 633():352-359. PubMed ID: 29597157
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
32. Pharmacists are key in interpreting clinical implications of N-nitrosodimethylamine contamination in medications.
Eads AV
J Am Pharm Assoc (2003); 2020; 60(6):e100-e104. PubMed ID: 32741598
[TBL] [Abstract][Full Text] [Related]
33. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
[TBL] [Abstract][Full Text] [Related]
34. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
35. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
36. Antisecretory and antiulcer effect of the H2-receptor antagonist famotidine in the rat: comparison with ranitidine.
Scarpignato C; Tramacere R; Zappia L
Br J Pharmacol; 1987 Sep; 92(1):153-9. PubMed ID: 2889492
[TBL] [Abstract][Full Text] [Related]
37. Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.
Howard JM; Chremos AN; Collen MJ; McArthur KE; Cherner JA; Maton PN; Ciarleglio CA; Cornelius MJ; Gardner JD; Jensen RT
Gastroenterology; 1985 Apr; 88(4):1026-33. PubMed ID: 2857672
[TBL] [Abstract][Full Text] [Related]
38. Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
Decktor DL; Pendleton RG; Kellner AT; Davis MA
J Pharmacol Exp Ther; 1989 Apr; 249(1):1-5. PubMed ID: 2565384
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
[TBL] [Abstract][Full Text] [Related]
40. NDMA formation kinetics from three pharmaceuticals in four water matrices.
Shen R; Andrews SA
Water Res; 2011 Nov; 45(17):5687-94. PubMed ID: 21903238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
